Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: A retrospective analysis of US health insurance claims data
JAAD International, ISSN: 2666-3287, Vol: 13, Page: 117-125
2023
- 2Citations
- 20Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Most Recent News
New Bullous Pemphigoid Research from AstraZeneca Outlined (Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: A retrospective analysis of US health insurance claims dataCapsule …): Autoimmu
NewsRx Pharma Business Daily 2023 DEC 07 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Pharma Business Daily -- Investigators publish new report
Article Description
Real-world data describing the impact of incident bullous pemphigoid (BP) on patients and health care resource utilization (HCRU) are limited. To examine characteristics, treatment patterns, HCRU, and costs for incident BP. Retrospective analysis of 2015 to 2019 US health insurance claims for patients ≥18 years with an incident BP diagnosis. Patients with BP were matched to those without on demographic and clinical characteristics. Statistics were descriptive. The mean Charlson Comorbidity Index score was higher for patients with BP ( n = 1108) than without ( n = 4621) at baseline (mean [SD]: 3.3 [2.7] vs 2.8 [2.4]) and during follow-up (5.0 [4.9] vs 3.7 [3.0]). Hypertension, diabetes, skin ulcers, chronic pulmonary disease, dyslipidemia, sleep disorders, and congestive heart failure were higher with BP. Most patients with BP received antibiotics (>80%) and/or corticosteroids (>90%). Hospitalizations were more common (44.0% vs 17.1%) and monthly all-cause health care costs more than double ($3214 vs $1353) in patients with BP than without. Diagnoses were based on billing codes. HCRU claims data may not reflect the true number of encounters. Incident BP is associated with considerable morbidity, HCRU, and costs. More effective, targeted treatments are needed to improve quality of life, while minimizing exposure to systemic corticosteroids.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2666328723000871; http://dx.doi.org/10.1016/j.jdin.2023.04.014; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85172675570&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/37808963; https://linkinghub.elsevier.com/retrieve/pii/S2666328723000871; https://dx.doi.org/10.1016/j.jdin.2023.04.014
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know